Published in Eur J Echocardiogr on December 01, 2002
The Need for Standardized Methods for Measuring the Aorta: Multimodality Core Lab Experience From the GenTAC Registry. JACC Cardiovasc Imaging (2016) 1.58
Core lab analysis of baseline echocardiographic studies in the STICH trial and recommendation for use of echocardiography in future clinical trials. J Am Soc Echocardiogr (2012) 1.13
Predictors of coronary artery visualization in Kawasaki disease. J Am Soc Echocardiogr (2011) 0.88
Is core laboratory essential for using echocardiography in clinical trials? Controlled vs random error. Eur J Echocardiogr (2002) 0.83
Acute Respiratory Distress Syndrome Measurement Error. Potential Effect on Clinical Study Results. Ann Am Thorac Soc (2016) 0.79
Phase II trials in heart failure: the role of cardiovascular imaging. Am Heart J (2011) 0.76
Reproducibility of left ventricular mass by echocardiogram in the ELSA-Brasil. Arq Bras Cardiol (2014) 0.75
Measurements of left ventricular volumes and ejection fraction with three-dimensional echocardiography: feasibility and agreement compared to two-dimensional echocardiography. Int J Cardiovasc Imaging (2014) 0.75
Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet (1981) 7.05
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet (2001) 6.31
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Benefit of a stroke unit: a randomized controlled trial. Stroke (1991) 3.13
The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med (1990) 2.85
Real-time strain rate imaging of the left ventricle by ultrasound. J Am Soc Echocardiogr (1998) 2.69
Coronary risk factors and socioeconomic status. The Oslo study. Lancet (1976) 2.67
Risk factors for sports injuries--a methodological approach. Br J Sports Med (2003) 2.59
Four-year mortality by some socioeconomic indicators: the Oslo study. J Epidemiol Community Health (1980) 2.48
Lung cancer and air pollution: a 27 year follow up of 16 209 Norwegian men. Thorax (2003) 2.43
A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome. Scand J Gastroenterol (2004) 2.37
Determination of cardiac output by Doppler echocardiography. Br Heart J (1984) 2.31
The Oslo study. Cardiovascular disease in middle-aged and young Oslo men. Acta Med Scand Suppl (1975) 2.30
Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J (1997) 2.07
Prevention of hamstring strains in elite soccer: an intervention study. Scand J Med Sci Sports (2007) 2.03
The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine (Phila Pa 1976) (1993) 2.01
Noninvasive estimation of valve area in patients with aortic stenosis by Doppler ultrasound and two-dimensional echocardiography. Circulation (1985) 2.01
Preventing injuries in female youth football--a cluster-randomized controlled trial. Scand J Med Sci Sports (2008) 1.90
Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet (1980) 1.75
Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure. Acta Med Scand (1976) 1.60
High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br Med J (1978) 1.50
Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma. Arteriosclerosis (1990) 1.46
Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol (2006) 1.46
Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study. Am J Med (1978) 1.42
Measurement of volumetric mitral and aortic blood flow based on a new freehand three-dimensional colour flow imaging method. An in vivo validation. Eur J Echocardiogr (2000) 1.39
[Doxazosin (Carduran)--a research survey]. Tidsskr Nor Laegeforen (1993) 1.39
Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations. Mov Disord (1994) 1.36
Oslo Study Diet and Antismoking Trial. Results after 102 months. Am J Med (1986) 1.35
Risk factors of stroke incidence and mortality. A 12-year follow-up of the Oslo Study. Stroke (1993) 1.31
The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med (2006) 1.29
Ethnicity and sex are strong determinants of diabetes in an urban Western society: implications for prevention. Diabetologia (2005) 1.28
Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care (1997) 1.27
Noninvasive estimation of systolic pressure in the right ventricle in patients with tricuspid regurgitation. Eur Heart J (1986) 1.26
Association of cardiac autonomic function and the development of hypertension: the ARIC study. Am J Hypertens (1996) 1.26
Early clinical screening of neonates for congenital heart defects: the cases we miss. Cardiol Young (1999) 1.25
Physical activity at work and at leisure in relation to coronary risk factors and social class. A 4-year mortality follow-up. The Oslo study. Acta Med Scand (1981) 1.22
Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study. Scand J Med Sci Sports (2007) 1.19
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. J Intern Med (1998) 1.18
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis (2010) 1.17
Coronary risk factors in various occupational groups: the Oslo study. Br J Prev Soc Med (1977) 1.16
Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. Am J Epidemiol (1989) 1.16
Possible metabolic side effects of beta-adrenergic blocking drugs. Br Med J (1978) 1.14
Outcome of congenital heart defects--a population-based study. Acta Paediatr (2000) 1.12
The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men. Prev Med (1985) 1.12
Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT. JAMA (1984) 1.10
High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study. Artery (1979) 1.09
Increasing incidence of ventricular septal defects caused by improved detection rate. Acta Paediatr (1994) 1.09
A new water-soluble, selective beta-blocker with intrinsic sympathomimetic activity (ICI 141.292) in angina pectoris. Acta Med Scand (1988) 1.08
Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo study. Am J Epidemiol (1980) 1.08
M-mode echocardiographic findings in apparently healthy, non-athletic Norwegians aged 20-70 years. Influence of age, sex and body surface area. J Intern Med (1989) 1.05
Strain rate imaging in normal and reduced diastolic function: comparison with pulsed Doppler tissue imaging of the mitral annulus. J Am Soc Echocardiogr (2001) 1.05
Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry (2001) 1.05
Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study. J Epidemiol Community Health (1996) 1.03
MAPHY and the two arms of HAPPHY. JAMA (1989) 1.01
Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr (2001) 0.99
Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology (1999) 0.97
[Mortality of Norwegian physicians in the period 1953-72 in relation to their smoking habits in 1952-3]. Tidsskr Nor Laegeforen (1976) 0.97
The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study. Acta Med Scand (1976) 0.97
Assessment of volar angulation and shortening in 5th metacarpal neck fractures: an inter- and intra-observer validity and reliability study. J Hand Surg Eur Vol (2012) 0.97
Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway. Scand J Med Sci Sports (2007) 0.97
Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals. J Clin Microbiol (2001) 0.96
High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. Blood Press Suppl (1992) 0.96
[Are the results of thallium scintigraphy and coronary angiography equivalent? An evaluation of thallium scintigraphies performed at Vestfold Central Hospital]. Tidsskr Nor Laegeforen (1993) 0.96
Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial. Kidney Int (2001) 0.96
Natural course of a prolonged PR interval and the relation between PR and incidence of coronary heart disease. A 7-year follow-up study of 1832 apparently healthy men aged 40-59 years. Clin Cardiol (1984) 0.95
Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects. 18-year follow-up of the Oslo Study. Stroke (1995) 0.95
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease. J Intern Med (2006) 0.95
Measuring left ventricular volume and ejection fraction with the biplane Simpson's method. Heart (2002) 0.92
Relationship between floor type and risk of ACL injury in team handball. Scand J Med Sci Sports (2003) 0.92
Strain rate imaging by ultrasonography in the diagnosis of coronary artery disease. J Am Soc Echocardiogr (2000) 0.92
A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis. Clin Rheumatol (1986) 0.91
Long term results after operative treatment of isolated ventricular septal defect in adolescents and adults. Acta Med Scand Suppl (1986) 0.91
Socio-economic status as a coronary risk factor: the Oslo study. Acta Med Scand Suppl (1982) 0.91
Association between the blood pressure response to a change in posture and the 6-year incidence of hypertension: prospective findings from the ARIC study. J Hum Hypertens (2002) 0.91
Extension of clinical trials. 10 1/2 year follow-up of the Multiple Risk Factor Intervention Trial. Circulation (1990) 0.91
Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females. Int J Clin Lab Res (1992) 0.91
Prognosis in cardiac pacing. A comparison between patients with atrioventricular block and sick sinus syndrome. Acta Med Scand (1981) 0.89
Half time of the diastolic aortoventricular pressure difference by continuous wave Doppler ultrasound: a measure of the severity of aortic regurgitation? Br Heart J (1989) 0.88
Risk factors associated with body mass index increase in men at 28 years follow-up. QJM (2006) 0.88
Coronary risk factors and their pathway of action through coronary raised lesions, coronary stenoses and coronary death. Multivariate statistical analysis of an autopsy series: the Oslo Study. Am J Cardiol (1985) 0.88
Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome. Nutr Metab Cardiovasc Dis (2009) 0.88
Cross-sectional early mitral flow-velocity profiles from color Doppler in patients with mitral valve disease. Circulation (1992) 0.87
Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report. Arterioscler Thromb Vasc Biol (1995) 0.87
The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders. Eur J Clin Nutr (2007) 0.87
Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries. Statistical analysis from the Oslo study. Arteriosclerosis (1981) 0.87
Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES). Blood Press (1995) 0.87
Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data. J Cardiovasc Risk (2001) 0.87
Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo Study. Lab Invest (1985) 0.86
The velocity distribution in the aortic anulus in normal subjects: a quantitative analysis of two-dimensional Doppler flow maps. J Am Soc Echocardiogr (1991) 0.85
Intrinsic risk factors for acute ankle injuries among male soccer players: a prospective cohort study. Scand J Med Sci Sports (2009) 0.85
The effect of exercise and diet on mental health and quality of life in middle-aged individuals with elevated risk factors for cardiovascular disease. J Sports Sci (1999) 0.85